Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

NCI Awards ATCC Task Order to Provide Cancer Epidemiology Services to Research Community

April 01, 2022

Under the two-year task order, ATCC will continue to support the DCEG MEAS program in receiving, processing, storing, analyzing, and distributing clinical specimens from different cancer types.

Emmes Acquires Rare-Disease CRO Casimir

March 18, 2022

Emmes has acquired Casimir, marking its fourth major acquisition.

Why Global Pharma Companies Aren’t Quitting China Anytime Soon

March 08, 2022

What if we are underestimating China’s response to US/EU inshoring?

Empowering Protein Characterization

March 02, 2022

Scientists can work to overcome the challenges associated with protein characterization through empowering technologies.

Cold Comfort for Bio/Pharma

March 02, 2022

Continuous improvements in technologies and services will help cold chain operators meet future industry demand.

Selecting and Optimizing the Right Manufacturing Partner

March 02, 2022

Optimizing the use of partners for clinical trials depends on selecting the right contractor.

Insights into Outsourced vs. In-house Clinical Trial Services

March 02, 2022

Capacity concerns and regulatory compliance considerations will drive the decision about outsourcing the manufacture of clinical trial materials.

Moderna and Thermo Fisher Scientific Form Long-Term Strategic Manufacturing Collaboration

February 23, 2022

Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.

Center for Breakthrough Medicines and BioAnalysis LLC Form Partnership to Offer Novel Analytical Testing Services for CGT Clients

February 23, 2022

The Center for Breakthrough Medicines and BioAnalysis LLC have formed a strategic alliance to offer novel analytical testing services for CGT clients.

Recipharm Acquires Two Biologics CDMOs: Vibalogics and Arranta Bio

February 21, 2022

Recipharm has strengthened its biologics manufacturing capabilities with the acquisition of both Vibalogics and Arranta Bio.